Lyme Disease Diagnostic Devices Market Size To Hit US$ 3.87 Billion By 2027

The global lyme disease diagnostic devices market size is expected to hit around USD 3.87 billion by 2027 and progressing a CAGR of 7.2% over the forecast period 2020 to 2027.

Lyme Disease Diagnostic Devices Market Size 2016 to 2027

The on lyme disease diagnostic devices Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1183

Report Scope of the Lyme Disease Diagnostic Devices Market

Report Highlights	Details
Market Size	USD 3.87 billion by 2027
Growth Rate	CAGR of 7.2% From 2021 to 2027
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2021
Forecast Period	2021 to 2027
Segments Covered	Product, End User, Region

A recent report provides crucial insights along with application based and forecast information in the Global Lyme disease diagnostic devices Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Lyme disease diagnostic devices market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Lyme disease diagnostic devices market are included as given below:

Lyme disease diagnostic devices Market Key Players

Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Boulder Diagnostics
T2 Biosystems, Inc.
Abbott
Oxford Immunotec Global PLC
Quidel Corporation
Affymetrix Inc.
Hoffmann-La Roche Ltd
Graphene Frontiers

Market Segments

By Product Type

Serological Test
Urine Antigen Tests
Lymphocytic Transformation Test
Immunofluorescent Staining
Nucleic acid Test

By End User

Hospitals
Public/Private Laboratories
Physician’s Office

By Geography

North America

U.S.
Canada

Europe

Germany
France
United Kingdom
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Rest of Latin America

Middle East & Africa (MEA)

GCC
North Africa
South Africa
Rest of Middle East & Africa

Report Objectives

To define, describe, and forecast the global lyme disease diagnostic devices market based on product, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the lyme disease diagnostic devices market

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Lyme End User Diagnostic Devices Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Lyme End User Diagnostic Devices Market

5.1. Covid-19: Lyme End User Diagnostic Devices Industry Impact
5.2. Lyme End User Diagnostic Devices Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Lyme End User Diagnostic Devices Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Lyme End User Diagnostic Devices Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Lyme End User Diagnostic Devices Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing prevalence of Lyme disease
6.1.1.2. Growing investment in research and development
6.1.2. Market Restraints
6.1.2.1. Lack of awareness
6.1.3. Market Opportunities
6.1.3.1. Technological advancements

Chapter 7. Global Lyme End User Diagnostic Devices Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Lyme End User Diagnostic Devices Market Revenue by Market Players (2016 -2019)
7.1.1.2. Lyme End User Diagnostic Devices Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Type Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Lyme End User Diagnostic Devices Market, By Product Type

8.1. Lyme End User Diagnostic Devices Market, by Product Type, 2016-2027
8.1.1. Serological Test
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Urine Antigen Tests
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Lymphocytic Transformation Test
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Immunofluorescent Staining
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Nucleic Acid Test
8.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Lyme End User Diagnostic Devices Market, By End User

9.1. Lyme End User Diagnostic Devices Market, by End User, 2016-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Public/Private Laboratories
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Physician’s Office
9.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Lyme End User Diagnostic Devices Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Product Type(2016-2027)
10.1.2. Market Revenue Forecast by End User (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type (2016-2027)
10.2.2. Market Revenue Forecast by End User (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type (2016-2027)
10.3.2. Market Revenue Forecast by End User (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type (2016-2027)
10.4.2. Market Revenue Forecast by End User (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type (2016-2027)
10.5.2. Market Revenue Forecast by End User (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2016-2027)

Chapter 11. Company Profiles

11.1. Bio-Rad Laboratories, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, End User
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, End User
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Boulder Diagnostics
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, End User
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. T2 Biosystems, Inc.
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, End User
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. Abbott
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, End User
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Oxford Immunotec Global PLC
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, End User
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Quidel Corporation
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, End User
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. Affymetrix Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, End User
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. F. Hoffmann-La Roche Ltd
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, End User
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Graphene Frontiers
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, End User
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies